Within these two gene sets, we found that ERG- patient-enriched CD4 T-cells, tumor cells, and stromal cells showed significantly higher expression of a family of HLA genes compared to ERG+ cell populations (P < 0.05, Wilcoxon rank-sum test) (Fig. 7g). The gene discussed is ERG; the disease is neoplasm.